Unlock regulatory insights with Watson. Learn More
Return to Docket

Refuse to Approve Dr. Reddy’s ANDA That cites Lunesta® as The Reference Listed Drug, Unless The Conditions Specified in The Petition Are Satisfied - CLOSED

Type: Non-Rule Making
KeyWord(s) cder, section 505 (q), anda no 91024, eszopclone tablets, Dr. Reddy's Laboratories, R-isomer, lunesta
Short title Refuse to Approve Dr. Reddy’s ANDA That cites Lunesta® as The Reference Listed Drug, Unless The Conditions Specified in The Petition Are Satisfied
Docket Item Code P
Center CDER

Supporting Documents (0)

Your search found no documents. Click here to search more.